Clinical Trial Update: The Unhide™ Project: Economic Impact Study of IVIG Treatment for PANS

View source ↗

Summary

A completed trial within the Unhide project evaluating the economic impact of intravenous immunoglobulin (IVIG) treatment for Pediatric Acute-onset Neuropsychia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute-onset Neuropsychiatric Syndrome
• Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Brain Inflammation Collaborative | Conditions: PANDAS, PANS | Status: COMPLETED